Product Description
Sorafenat Sorafenib Tablets by Natco Pharma Limited deliver a sizzling treatment for advanced liver, kidney, and thyroid cancers at an unbeatable price, ensuring enviable savings for patients. These lustrous, reddish brown, oval-shaped tablets (200 mg each) are a soaring choice for adults striving against cancer. Boasting a robust formulation of Sorafenib Tosylate, Sorafenat is a potent tyrosine kinase inhibitor, authenticated for efficacy and safety. As a prescription-only, solid oral anti-cancer medicine, it is recommended to be used strictly under qualified medical supervision.
Effective Application and Specialized Use
Sorafenat Sorafenib Tablets are specifically indicated for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma. Designed for adult patients, this oral anti-cancer medication inhibits tumor growth at the molecular level, offering hope for those with difficult-to-treat cancers. The extra features of Sorafenat include its solid oral form for convenient dosing and comprehensive application for liver, kidney, and thyroid cancers, as guided by expert healthcare professionals.
Packaging, Logistics, and Main Domestic Market
Sorafenat Sorafenib Tablets come securely packaged in bottles containing 120 tablets each, ensuring product safety and integrity during transit. The logistics are streamlined for export, supply, and trading, with efficient delivery times depending on location within the main domestic market-India. Advanced packaging safeguards the tablets from moisture and light, preserving their efficacy until the expiry date. This ensures patients receive the medication in optimal condition, whenever and wherever required within the country.
FAQ's of Sorafenat Sorafenib Tablets:
Q: How should Sorafenat Sorafenib Tablets be administered?
A: Sorafenat tablets are intended for oral use and should be taken as prescribed by a qualified healthcare professional. Always follow your doctor's instructions regarding dosage and frequency.
Q: What cancers are treated with Sorafenat Sorafenib Tablets?
A: These tablets are recommended for the management of advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma, as directed by a physician.
Q: When can patients expect to start their Sorafenat therapy after prescription?
A: Once prescribed, therapy can begin as soon as the medication is obtained and proper instructions are given by a healthcare provider. Delivery times may vary by region within India.
Q: Where are Sorafenat Sorafenib Tablets manufactured and available?
A: Sorafenat is manufactured by Natco Pharma Limited in India and is available across the domestic market through authorized exporters, suppliers, and traders.
Q: What are the main benefits of using Sorafenat for cancer treatment?
A: Sorafenat offers targeted action against cancer cells as a tyrosine kinase inhibitor, making it a potent option for patients with advanced stages of liver, kidney, or thyroid cancers.
Q: What side effects should be monitored when using Sorafenat?
A: Possible side effects include fatigue, diarrhea, loss of appetite, hypertension, and skin rash. It is important to consult a physician if any side effects occur or persist.